Cargando…
Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness
SIMPLE SUMMARY: Breast cancer is a heterogeneous disease that has complex causes and mechanisms of development. Currently, patient treatment options depend on the breast cancer molecular subtype, which is classified based on the presence or absence of hormone receptors and HER2. However, this classi...
Autores principales: | Oh, Chaeun, Kim, Hwa-Ryeon, Oh, Sumin, Ko, Je Yeong, Kim, Yesol, Kang, Keunsoo, Yang, Young, Kim, Jongmin, Park, Jong Hoon, Roe, Jae-Seok, Yoo, Kyung Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268034/ https://www.ncbi.nlm.nih.gov/pubmed/34202157 http://dx.doi.org/10.3390/cancers13133176 |
Ejemplares similares
-
Functional roles of CTCF in breast cancer
por: Oh, Sumin, et al.
Publicado: (2017) -
Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma
por: Bi, Shui-Qing, et al.
Publicado: (2022) -
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer
por: Kim, Yesol, et al.
Publicado: (2022) -
Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development
por: Ko, Je Yeong, et al.
Publicado: (2017) -
Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)